Packages were shipped directly to an ISO-certified analytical facility that specializes in dietary supplement screening
In the Phase 2 fatty-liver subgroup, liver fat fell by half at the bottom dose and by most at the top. Those figures describe the studied cohorts, and the Phase 3 weight result remains company-reported
In May 2026, Eli Lilly announced it will present highly anticipated data on Foundayo, Mounjaro, and retatrutide at the American Diabetes Associations (ADA) 86th Scientific Sessions
According to the Phase 3 trial involving around 2,500 patients, people taking the highest dose of Retatrutide lost an average of 28.3 per cent of their body weight, approximately 70 pounds, over 80 weeks
We are also planning for a few face to face sessions with Ana Terra, a certified nutritionist